Literature DB >> 25102991

Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.

Tony N Marion1, Arnold E Postlethwaite.   

Abstract

Systemic lupus erythematosus (SLE) is a remarkably complex and heterogeneous systemic autoimmune disease. Disease complexity within individuals and heterogeneity among individuals, even genetically identical individuals, is driven by stochastic execution of a complex inherited program. Genome-wide association studies (GWAS) have progressively improved understanding of which genes are most critical to the potential for SLE and provided illuminating insight about the immune mechanisms that are engaged in SLE. What initiates expression of the genetic program to cause SLE within an individual and how that program is initiated remains poorly understood. If we extrapolate from all of the different experimental mouse models for SLE, we can begin to appreciate why SLE is so heterogeneous and consequently why prediction of disease outcome is so difficult. In this review, we critically evaluate extrinsic versus intrinsic cellular functions in the clearance and elimination of cellular debris and how dysfunction in that system may promote autoimmunity to nuclear antigens. We also examine several mouse models genetically prone to SLE either because of natural inheritance or inheritance of induced mutations to illustrate how different immune mechanisms may initiate autoimmunity and affect disease pathogenesis. Finally, we describe the heterogeneity of disease manifestations in SLE and discuss the mechanisms of disease pathogenesis with emphasis on glomerulonephritis. Particular attention is given to discussion of how anti-DNA autoantibody initiates experimental lupus nephritis (LN) in mice.

Entities:  

Mesh:

Year:  2014        PMID: 25102991     DOI: 10.1007/s00281-014-0440-x

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  347 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

2.  Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors:  K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

3.  Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus.

Authors:  Takahisa Gono; Yasushi Kawaguchi; Hirotaka Kaneko; Katsuji Nishimura; Masanori Hanaoka; Sayuri Kataoka; Yuko Okamoto; Yasuhiro Katsumata; Hisashi Yamanaka
Journal:  Rheumatology (Oxford)       Date:  2011-01-05       Impact factor: 7.580

4.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

Authors:  Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; Timothy W Behrens
Journal:  N Engl J Med       Date:  2008-01-20       Impact factor: 91.245

5.  Cardiac involvement in systemic lupus erythematosus detected by echocardiography.

Authors:  I G Crozier; E Li; M J Milne; M G Nicholls
Journal:  Am J Cardiol       Date:  1990-05-01       Impact factor: 2.778

6.  Interleukin 10 secretion in relation to human IL-10 locus haplotypes.

Authors:  J Eskdale; G Gallagher; C L Verweij; V Keijsers; R G Westendorp; T W Huizinga
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  Polyreactive autoantibodies are nephritogenic in murine lupus nephritis.

Authors:  O G Pankewycz; P Migliorini; M P Madaio
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

8.  Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13.

Authors:  Terukazu Enami; Takeshi Suzuki; Satoshi Ito; Ai Yoshimi; Makoto Sugihara; Mizuko Mamura; Taichi Hayashi; Daisuke Goto; Isao Matsumoto; Akito Tsutsumi; Takayuki Sumida
Journal:  Intern Med       Date:  2007-07-02       Impact factor: 1.271

9.  Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production.

Authors:  Sharon A Chung; Kimberly E Taylor; Robert R Graham; Joanne Nititham; Annette T Lee; Ward A Ortmann; Chaim O Jacob; Marta E Alarcón-Riquelme; Betty P Tsao; John B Harley; Patrick M Gaffney; Kathy L Moser; Michelle Petri; F Yesim Demirci; M Ilyas Kamboh; Susan Manzi; Peter K Gregersen; Carl D Langefeld; Timothy W Behrens; Lindsey A Criswell
Journal:  PLoS Genet       Date:  2011-03-03       Impact factor: 5.917

10.  Peripheral blood monocyte gene expression profile clinically stratifies patients with recent-onset type 1 diabetes.

Authors:  Katharine M Irvine; Patricia Gallego; Xiaoyu An; Shannon E Best; Gethin Thomas; Christine Wells; Mark Harris; Andrew Cotterill; Ranjeny Thomas
Journal:  Diabetes       Date:  2012-03-08       Impact factor: 9.461

View more
  25 in total

Review 1.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 2.  Antigen-specific immunotherapies in rheumatic diseases.

Authors:  Judit Pozsgay; Zoltán Szekanecz; Gabriella Sármay
Journal:  Nat Rev Rheumatol       Date:  2017-07-13       Impact factor: 20.543

Review 3.  Pathogenesis of proliferative lupus nephritis from a historical and personal perspective.

Authors:  Shu Man Fu; Hongyang Wang; Chao Dai; Sun-Sang J Sung; Felicia Gaskin
Journal:  Clin Immunol       Date:  2016-08-31       Impact factor: 3.969

Review 4.  Epigenetics and Systemic Lupus Erythematosus: Unmet Needs.

Authors:  Pier Luigi Meroni; Alessandra Emiliana Penatti
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

5.  Lupus Susceptibility Loci Predispose Mice to Clonal Lymphocytic Responses and Myeloid Expansion.

Authors:  Elliot H Akama-Garren; Michael C Carroll
Journal:  J Immunol       Date:  2022-04-27       Impact factor: 5.426

6.  Epidermal injury promotes nephritis flare in lupus-prone mice.

Authors:  Kaitlyn L Clark; Tamra J Reed; Sonya J Wolf; Lori Lowe; Jeffrey B Hodgin; J Michelle Kahlenberg
Journal:  J Autoimmun       Date:  2015-08-21       Impact factor: 7.094

Review 7.  Developmental origin and sex-specific risk for infections and immune diseases later in life.

Authors:  Dimitra E Zazara; Petra Clara Arck
Journal:  Semin Immunopathol       Date:  2018-10-08       Impact factor: 9.623

Review 8.  An Update for Mesenchymal Stem Cell Therapy in Lupus Nephritis.

Authors:  Wenchao Li; Weiwei Chen; Lingyun Sun
Journal:  Kidney Dis (Basel)       Date:  2021-02-19

9.  A single-cell survey of the human glomerulonephritis.

Authors:  Zhejun Chen; Ting Zhang; Kaiqiong Mao; Xinghua Shao; Yao Xu; Minyan Zhu; Hang Zhou; Qin Wang; Zhenyuan Li; YuanYuan Xie; Xiaodong Yuan; Liang Ying; Ming Zhang; Jiajia Hu; Shan Mou
Journal:  J Cell Mol Med       Date:  2021-03-22       Impact factor: 5.310

10.  Interpretable machine learning identifies paediatric Systemic Lupus Erythematosus subtypes based on gene expression data.

Authors:  Jennifer R S Meadows; Jan Komorowski; Sara A Yones; Alva Annett; Patricia Stoll; Klev Diamanti; Linda Holmfeldt; Carl Fredrik Barrenäs
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.